不同HBsAg水平的慢性乙型肝炎患者血清HIF-1α、ApoE和TGF-β1水平变化及其临床意义探讨

doi:10.3969/j.issn.1672-5069.2023.01.036

Journal of Practical Hepatology ›› 2023, Vol. 26 ›› Issue (1): 140-141.doi: 10.3969/j.issn.1672-5069.2023.01.036

Previous Articles Next Articles

Changes of serum HIF-1α, ApoE and TGF-β1 levels in patients with chronic hepatitis B with different serum HBsAg levels

Jia Chunfeng, Gao Xuan, Xu Qian, et al

Clinical Laboratory, Rehabilitation Hospital, Capital Medical University, Beijing 100144, China

Received:2022-10-28 Online:2023-01-10 Published:2023-02-07

Abstract

Jia Chunfeng, Gao Xuan, Xu Qian, et al. Changes of serum HIF-1α, ApoE and TGF-β1 levels in patients with chronic hepatitis B with different serum HBsAg levels[J]. Journal of Practical Hepatology, 2023, 26(1): 140-141.

[1]	Sun Donglei, Guo Jinbo, Wang Dandan, et al. Effect of exosomes derived from mesenchymal stem cells on the proliferation and activation of hepatic stellate cells in vitro [J]. Journal of Practical Hepatology, 2023, 26(1): 11-14.
[2]	Zhang Dan, Jiang Jianxin. Comparison of response to recombinant cytokine gene-derived protein or human interferon α-2b and entecavir combination in the treatment of patients with serum HBeAg positive chronic hepatitis B [J]. Journal of Practical Hepatology, 2023, 26(1): 27-30.
[3]	He Xiaojin, Li Dan, Zhou Qing, et al.. Expression of hepatitis B virus X protein and suppressor of cytokine signaling-1 in L02 cells in vitro [J]. Journal of Practical Hepatology, 2022, 25(6): 772-775.
[4]	Li Xiangyang, Ding Guangwei, Jin Ming. Efficacy of entecavir in treatment of patients with chronic hepatitis B and non-alcoholic fatty liver diseases [J]. Journal of Practical Hepatology, 2022, 25(6): 776-779.
[5]	Wu Fengping, Cui Dandan, Wang Yikai, et al.. Serum B-cell activating factor levels in predicting antiviral response of pegylated interferon alpha in inactive HBsAg carriers [J]. Journal of Practical Hepatology, 2022, 25(6): 780-783.
[6]	Qi Xiaoan, Lu Jinxi, Yuan Lin. Correlation of polymorphisms of calcitonin gene-related peptide and α-interferon-λ4 genes to response to α-interferon therapy in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2022, 25(6): 784-787.
[7]	Li Rong, Cao Jingjing, Li Jing, et al.. Triggering and impacting factors of prognosis in patients with hepatitis B virus-associated acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2022, 25(6): 832-835.
[8]	Lin Xiuhui, Li Nan, Zhang Jiaozhen, et al.. Polymorphisms of PNPLA3 and PRKAA1 genes and their correlation to liver cirrhosis in patients with hepatitis B viral infection [J]. Journal of Practical Hepatology, 2022, 25(6): 844-847.
[9]	Wang Yushan, Kong Yin, Liu Yuanyuan, et al.. Different switching therapy for chronic hepatitis B patients with low-level viraemia : a single-center retrospective study [J]. Journal of Practical Hepatology, 2022, 25(5): 633-636.
[10]	Xu Huan, Tan Junyuan, Huang He, et al.. Antiviral response and changes of TLR4 and B7-H1 in peripheral blood mononuclear cells by peginterferon α-2a and entecavir combination therapy in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2022, 25(5): 637-640.
[11]	Wang Chunying, Qu Yaoning, Qiao Wei, et al.. Implication of serum HBV cccDNA and HBV pgRNA in patients with chronic hepatitis B receiving entecavir therapy [J]. Journal of Practical Hepatology, 2022, 25(5): 641-644.
[12]	Mo Jinying, Yu Xi, Yu Xueping, et al. Diagnostic performance of FibroTouch scan in identifying liver fibrosis in hepatitis B virus carriers [J]. Journal of Practical Hepatology, 2022, 25(4): 480-483.
[13]	Xiong Xiali, Wei Hong, Zhu Yunxia, et al. Safety of tenofovir disoproxil fumarate in pregnant women with HBV infection: An observation on renal functions and fetal growths [J]. Journal of Practical Hepatology, 2022, 25(4): 484-487.
[14]	Jia Ting, Li Junyi, Zhang Xiuling, et al. Serologic response toentecavir and pegylated interferon α-2b combination in treatment of patients with low serum level HBsAg-positive chronic hepatitis B [J]. Journal of Practical Hepatology, 2022, 25(4): 488-491.
[15]	Liu Yuying, Zhang Jiaozhen, Zhou Haijuan, et al. Response to tenofovir antiviral therapy different in patients with chronic hepatitis B and different HBV genotype infection? [J]. Journal of Practical Hepatology, 2022, 25(4): 492-495.

Changes of serum HIF-1α, ApoE and TGF-β1 levels in patients with chronic hepatitis B with different serum HBsAg levels

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments